Evidence for glial-mediated inflammation in aged APP(SW) transgenic mice

Neurobiology of Aging

Volumn 20, Issue 6, 1999, Pages 581-589

  Benzing, W C ^a   Wujek, J R ^a   Ward, E K ^a   Shaffer, D ^a   Ashe, K H ^b   Younkin, S G ^c   Brunden, K R ^a  

^a GUILFORD PHARMACEUTICALS INC   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Alzheimer's disease; Animal model; Cytokine; Glia; IL 1 ; IL 6; Immunocytochemistry; Inflammation; Mouse; TNF; Transgenic

Indexed keywords

AMYLOID; BIOCHEMICAL MARKER; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; MICROGLIA; MOUSE; NEUROGENIC INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

AGING; ALZHEIMER DISEASE; ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTERLEUKIN-1; MICE; MICE, TRANSGENIC; NEUROGLIA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033370498     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(99)00065-2     Document Type: Article

References (54)

1. Andersen K., Launer L.J., Ott A., Hoes A.W., Breteler M.M., Hofman A. Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study Neurology. 45:1995;1441-1445.
2. Beard C.M., Waring S.C., O'Brien P.C., Kurland L.T., Kokmen E. Nonsteroidal anti-inflammatory drug use and Alzheimer's disease a case-control study in Rochester, Minnesota, 1980 through 1984 . Mayo Clin Proc. 73:1998;951-955.
3. Benzing W.C., Ikonomovic M.D., Brady D.R., Mufson E.J., Armstrong D.M. Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease. J Comp Neurol. 334:1993;176-191.
4. Benzing W.C., Kordower J.H., Mufson E.J. Galanin immunoreactivity within the primate basal forebrain evolutionary change between monkeys and apes . J Comp Neurol. 336:1993;31-39.
5. Blum-Degen D., Muller T., Kuhn W., Gerlach M., Przuntek H., Riederer P. IL-1β and IL-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci Lett. 202:1995;17-20.
6. Cacabelos R., Alvarez X.A., Fernandez-Novoa L., Franco A., Mangues R., Pellicer A., Nishimura T. Brain IL-1 beta in Alzheimer's disease and vascular dementia. Methods Find Exp Clin Pharmacol. 16:1994;141-151.
7. Cai X.D., Golde T.E., Younkin S.G. Release of excess amyloid beta-protein from a mutant amyloid beta-protein precursor. Science. 259:1993;514-516.
8. Chapman P.F., White G.L., Jones M.W., Cooper-Blacketer D., Marshall V.J., Irizarry M., Younkin L., Good M.A., Bliss T.V., Hyman B.T., Younkin S.G., Hsiao K.K. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat Neurosci. 2:1999;271-276.
9. Chartier-Harlin M.C., Crawford F., Hamandi K., Mullan M., Goate A., Hardy J., Backhovens H., Martin J.J., Vanbroeckhoven C. Screening for the β-amyloid precursor protein mutation (APP717-Val- > Ile) in extended pedigrees with early onset Alzheimer's disease. Neurosci Lett. 129:1991;134-135.
10. Chen K.S., Masliah E., Grajeda H., Guido T., Huang J., Khan K., Motter R., Soriano F., Games D. Neurodegenerative Alzheimer-like pathology in PDAPP 717V- > F transgenic mice. Prog Brain Res. 117:1998;327-334.
11. Citron M., Oltersdorf T., Haass C., Mcconlogue L., Hung A.Y., Seubert P., Vigopelfrey C., Lieberburg I., Selkoe D.J. Mutation of the beta-amyloid precursor protein in familial Azheimer's disease increases beta-protein production. Nature. 360:1992;672-674.
12. Cole G.M., Yang F., Chen P.P., Frautschy S.A., Hsiao K. Caspase activation and synapse loss in aged APPsw transgenic mice and Alzheimer's disease. Soc Neurosci Abstr. 24:1998;1503.
13. Combs C.K., Johnson D.E., Cannady S.B., Lehman T.M., Landreth G.E. Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-amyloid and prion proteins. J Neurosci. 19:1999;928-939.
14. Duff K., Eckman C., Zehr C., Yu X., Prada C.M., Perez-tur J., Hutton M., Buee L., Harigaya Y., Yager D., Morgan D., Gordon M.N., Holcomb L., Refolo L., Zenk B., Hardy J., Younkin S. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin-1. Nature. 383:1996;710-713.
15. El Khoury J., Hickman S.E., Thomas C.A., Cao L., Silverstein S.C., Loike J.D. Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature. 382:1996;716-719.
16. Fillit H., Ding W.H., Buee L., Kalman J., Altstiel L., Lawlor B., Wolf-Klein G. Elevated circulating TNF levels in Alzheimer's disease. Neurosci Lett. 129:1991;318-320.
17. Frautschy S.A., Yang F., Irrizarry M., Hyman B., Saido T.C., Hsiao K., Cole G.M. Microglial response to amyloid plaques in APPsw transgenic mice. Am J Pathol. 152:1998;307-317.
18. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagopian S., Johnsonwood K., Khan K., Lee M., Leibowitz P., Lieberburg I., Little S., Masliah E., Mcconlogue L., Montoyazavala M., Mucke L., Paganini L., Penniman E., Power M., Schenk D., Seubert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., Zhao J. Alzheimer-type neuropathology in transgenic mice overexpressing v717f beta-amyloid precursor protein. Nature. 373:1995;523-527.
19. Goate A.M. Monogenetic determinants of Alzheimer's disease APP mutations . Cell Mol Life Sci. 54:1998;897-901.
20. Griffin W.S., Sheng J.G., Roberts G.W., Mrak R.E. IL-1 expression in different plaque types in Alzheimer's disease significance in plaque evolution . J Neuropathol Exp Neurol. 54:1995;276-281.
21. Griffin W.S., Stanley L.C., Ling C., White L., MacLeod V., Perrot L.J., White C.L., Araoz C. Brain IL-1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA. 86:1989;7611-7615.
22. Haga S., Akai K., Ishii T. Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain. An immunohistochemical study using a novel monoclonal antibody. Acta Neuropathol (Berl). 77:1989;569-575.
23. Hardy J., Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci. 12:1991;383-388.
24. Harpin M.L., Delaere P., Javoy-Agid F., Bock E., Jacque C., Delpech B., Villarroya H., Duyckaerts C., Hauw J.J., Baumann N. Glial fibrillary acidic protein and beta A4 protein deposits in temporal lobe of aging brain and senile dementia of the Alzheimer type relation with the cognitive state and with quantitative studies of senile plaques and neurofibrillary tangles . J Neurosci Res. 27:1990;587-594.
25. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
26. Ikeda S., Yanagisawa N., Allsop D., Glenner G.G. Early senile plaques in Alzheimer's disease demonstrated by histochemistry, immunocytochemistry, and electron microscopy. Hum Pathol. 21:1990;1221-1226.
27. Irizarry M.C., McNamara M., Fedorchak K., Hsiao K., Hyman B.T. APPsw transgenic mice develop age-related Aβ deposits and neuropil abnormalities, but no neuronal loss in CA1. J Neuropathol Exp Neurol. 56:1997;965-973.
28. Itagaki S., McGeer P.L., Akiyama H., Zhu S., Selkoe D. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol. 24:1989;173-182.
29. Kalman J., Juhasz A., Laird G., Dickens P., Jardanhazy T., Rimanoczy A., Boncz I., Parry-Jones W.L., Janka Z. Serum IL-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease. Acta Neurol Scand. 96:1997;236-240.
30. Katzman R., Terry R., DeTeresa R., Brown T., Davies P., Fuld P., Renbing X., Peck A. Clinical, pathological, and neurochemical changes in dementia A subgroup with preserved mental status and numerous neocortical plaques . Ann Neurol. 23:1988;138-144.
31. Kelenyi G. On the histochemistry of azo group-free thiazole dyes. J Histochem Cytochem. 15:1967;172-180.
32. Klegeris A., Walker D.G., McGeer P.L. Interaction of Alzheimer beta-amyloid peptide with the human monocytic cell line THP-1 results in a protein kinase C-dependent secretion of TNF-alpha. Brain Res. 747:1997;114-121.
33. Levy-Lahad E., Wasco W., Poorkaj P., Romano D.M., Oshima J., Pettingell W.H., Yu C.E., Jondro P.D., Schmidt S.D., Wang K. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 269:1995;973-977.
34. Lorton D., Kocsis J.M., King L., Madden K., Brunden K.R. β-Amyloid induces increased release of IL-1β from lipopolysaccharide-activated human monocytes. J Neuroimmunol. 67:1996;21-29.
35. Masliah E., Cole G.M., Hansen L.A., Mallory M., Albright T., Terry R.D., Saitoh T. Protein kinase-C alteration is an early biochemical marker in Alzheimer's disease. J Neurosci. 11:1991;2759-2767.
36. Masliah E., Mallory M., Hansen L., Alford M., Albright T., Terry R., Shapiro P., Sundsmo M., Saitoh T. Immunoreactivity of CD45, a protein phosphotyrosine phosphatase, in Alzheimer's disease. Acta Neuropathol (Berl). 83:1991;12-20.
37. Masliah E., Sisk A., Mallory M., Mucke L., Schenk D., Games D. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease. J Neurosci. 16:1996;5795-5811.
38. McDonald D.R., Brunden K.R., Landreth G.E. Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia. J Neurosci. 17:1997;2284-2294.
39. McGeer E.G., McGeer P.L. The importance of inflammatory mechanisms in Alzheimer disease. Exp Gerontol. 33:1998;371-378.
40. McGeer P.L., Itagaki S., Tago H., McGeer E.G. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Lett. 79:1987;195-200.
41. McGeer P.L., Schulzer M., McGeer E.G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease a review of 17 epidemiologic studies . Neurology. 47:1996;425-432.
42. Meda L., Cassatella M.A., Szendrei G.I., Otvos L.J., Baron P., Villalba M., Ferrari D., Rossi F. Activation of microglial cells by beta-amyloid protein and interferon- gamma. Nature. 374:1995;647-650.
43. Mrak R.E., Sheng J.G., Griffin W.S. Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease. J Neuropathol Exp Neurol. 55:1996;273-279.
44. Mullan M., Crawford F., Axelman K., Houlden H., Lilius L., Winblad B., Lannfelt L. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the n-terminus of β-amyloid. Nat Genet. 1:1992;345-347.
45. Murrell J., Farlow M., Ghetti B., Benson M.D. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science. 254:1991;97-99.
46. Probst A., Heitz P.U., Ulrich J. Histochemical analysis of senile plaque amyloid and amyloid angiopathy. Virchows Arch [Pathol Anat]. 388:1980;327-334.
47. Rogers J., Webster S., Lue L.F., Brachova L., Civin W.H., Emmerling M., Shivers B., Walker D., McGeer P. Inflammation, and Alzheimer's disease pathogenesis. Neurobiol Aging. 17:1996;681-686.
48. Scheuner D., Eckman C., Jensen M., Song X., Citron M., Suzuki N., Bird T.D., Hardy J., Hutton M., Kukull W., Larson E., Levy-Lahad E., Viitanen M., Peskind E., Poorkaj P., Schellenberg G., Tanzi R., Wasco W., Lannfelt L., Selkoe D., Younkin S. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med. 2:1996;864-870.
49. Singh V.K., Guthikonda P. Circulating cytokines in Alzheimer's disease. J Psychiatry Res. 31:1997;657-660.
50. Smith M.A., Hirai K., Hsiao K., Pappolla M.A., Harris P.L., Siedlak S.L., Tabaton M., Perry G. Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem. 70:1998;2212-2215.
51. Sturchler-Pierrat C., Abramowski D., Duke M., Wiederhold K.H., Mistl C., Rothacher S., Ledermann B., Burki K., Frey P., Paganetti P.A., Waridel C., Calhoun M.E., Jucker M., Probst A., Staufenbiel M., Sommer B. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA. 94:1997;13287-13292.
52. Suzuki N., Cheung T.T., Cai X.D., Odaka A., Otvos L.J., Eckman C., Golde T.E., Younkin S.G. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science. 264:1994;1336-1340.
53. Terry R.D., Katzman R. Senile dementia of the Alzheimer type. Ann Neurol. 14:1983;497-506.
54. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., Schmidt A.M. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature. 382:1996;685-691.